ID   TNKS1_HUMAN             Reviewed;        1327 AA.
AC   O95271; O95272; Q4G0F2; Q59FX0;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 2.
DT   18-JUN-2025, entry version 227.
DE   RecName: Full=Poly [ADP-ribose] polymerase tankyrase-1 {ECO:0000305};
DE            EC=2.4.2.30 {ECO:0000269|PubMed:19759537};
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 5 {ECO:0000303|PubMed:20106667};
DE            Short=ARTD5 {ECO:0000303|PubMed:20106667};
DE   AltName: Full=Poly [ADP-ribose] polymerase 5A {ECO:0000303|PubMed:20106667};
DE   AltName: Full=Protein poly-ADP-ribosyltransferase tankyrase-1 {ECO:0000305};
DE            EC=2.4.2.- {ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:25043379};
DE   AltName: Full=TNKS-1;
DE   AltName: Full=TRF1-interacting ankyrin-related ADP-ribose polymerase;
DE   AltName: Full=Tankyrase I;
DE   AltName: Full=Tankyrase-1 {ECO:0000303|PubMed:9822378};
DE            Short=TANK1 {ECO:0000303|PubMed:9822378};
GN   Name=TNKS {ECO:0000312|HGNC:HGNC:11941};
GN   Synonyms=PARP5A {ECO:0000303|PubMed:9822378}, PARPL, TIN1, TINF1,
GN   TNKS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=9822378; DOI=10.1126/science.282.5393.1484;
RA   Smith S., Giriat I., Schmitt A., de Lange T.;
RT   "Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.";
RL   Science 282:1484-1487(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3] {ECO:0000312|EMBL:BAD92576.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 273-1327.
RC   TISSUE=Brain {ECO:0000312|EMBL:BAD92576.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10523501; DOI=10.1242/jcs.112.21.3649;
RA   Smith S., de Lange T.;
RT   "Cell cycle dependent localization of the telomeric PARP, tankyrase, to
RT   nuclear pore complexes and centrosomes.";
RL   J. Cell Sci. 112:3649-3656(1999).
RN   [6]
RP   FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=10988299; DOI=10.1074/jbc.m007635200;
RA   Chi N.-W., Lodish H.F.;
RT   "Tankyrase is a Golgi-associated mitogen-activated protein kinase substrate
RT   that interacts with IRAP in GLUT4 vesicles.";
RL   J. Biol. Chem. 275:38437-38444(2000).
RN   [7]
RP   INTERACTION WITH NUMA1.
RX   PubMed=12080061; DOI=10.1074/jbc.m203916200;
RA   Sbodio J.I., Chi N.W.;
RT   "Identification of a tankyrase-binding motif shared by IRAP, TAB182, and
RT   human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a
RT   novel tankyrase partner.";
RL   J. Biol. Chem. 277:31887-31892(2002).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF HIS-1184 AND GLU-1291.
RX   PubMed=11739745; DOI=10.1128/mcb.22.1.332-342.2002;
RA   Cook B.D., Dynek J.N., Chang W., Shostak G., Smith S.;
RT   "Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at
RT   human telomeres.";
RL   Mol. Cell. Biol. 22:332-342(2002).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH POT1; TERF1 AND TINF2.
RX   PubMed=12768206; DOI=10.1038/nature01688;
RA   Loayza D., De Lange T.;
RT   "POT1 as a terminal transducer of TRF1 telomere length control.";
RL   Nature 423:1013-1018(2003).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16076287; DOI=10.1042/bj20050885;
RA   Chang W., Dynek J.N., Smith S.;
RT   "NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in
RT   mitosis.";
RL   Biochem. J. 391:177-184(2005).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND INTERACTION WITH
RP   AXIN1 AND AXIN2.
RX   PubMed=19759537; DOI=10.1038/nature08356;
RA   Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F., Michaud G.A.,
RA   Charlat O., Wiellette E., Zhang Y., Wiessner S., Hild M., Shi X.,
RA   Wilson C.J., Mickanin C., Myer V., Fazal A., Tomlinson R., Serluca F.,
RA   Shao W., Cheng H., Shultz M., Rau C., Schirle M., Schlegl J., Ghidelli S.,
RA   Fawell S., Lu C., Curtis D., Kirschner M.W., Lengauer C., Finan P.M.,
RA   Tallarico J.A., Bouwmeester T., Porter J.A., Bauer A., Cong F.;
RT   "Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.";
RL   Nature 461:614-620(2009).
RN   [12]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [13]
RP   FUNCTION, INTERACTION WITH AXIN1; AXIN2; BLZF1 AND CASC3, AND
RP   UBIQUITINATION.
RX   PubMed=21478859; DOI=10.1038/ncb2222;
RA   Zhang Y., Liu S., Mickanin C., Feng Y., Charlat O., Michaud G.A.,
RA   Schirle M., Shi X., Hild M., Bauer A., Myer V.E., Finan P.M., Porter J.A.,
RA   Huang S.M., Cong F.;
RT   "RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin
RT   degradation and Wnt signalling.";
RL   Nat. Cell Biol. 13:623-629(2011).
RN   [14]
RP   INTERACTION WITH AXIN1, AND SUBCELLULAR LOCATION.
RX   PubMed=21799911; DOI=10.1371/journal.pone.0022595;
RA   Callow M.G., Tran H., Phu L., Lau T., Lee J., Sandoval W.N., Liu P.S.,
RA   Bheddah S., Tao J., Lill J.R., Hongo J.A., Davis D., Kirkpatrick D.S.,
RA   Polakis P., Costa M.;
RT   "Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt
RT   signaling.";
RL   PLoS ONE 6:E22595-E22595(2011).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22864114; DOI=10.1016/j.molcel.2012.06.033;
RA   Ozaki Y., Matsui H., Asou H., Nagamachi A., Aki D., Honda H., Yasunaga S.,
RA   Takihara Y., Yamamoto T., Izumi S., Ohsugi M., Inaba T.;
RT   "Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome
RT   maturation.";
RL   Mol. Cell 47:694-706(2012).
RN   [16]
RP   FUNCTION.
RX   PubMed=23622245; DOI=10.1016/j.cell.2013.03.040;
RA   Cho-Park P.F., Steller H.;
RT   "Proteasome regulation by ADP-ribosylation.";
RL   Cell 153:614-627(2013).
RN   [17]
RP   FUNCTION.
RX   PubMed=25043379; DOI=10.1038/ncomms5426;
RA   Vyas S., Matic I., Uchima L., Rood J., Zaja R., Hay R.T., Ahel I.,
RA   Chang P.;
RT   "Family-wide analysis of poly(ADP-ribose) polymerase activity.";
RL   Nat. Commun. 5:4426-4426(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1091-1325, AND ZINC-BINDING SITES.
RX   PubMed=18436240; DOI=10.1016/j.jmb.2008.03.058;
RA   Lehtio L., Collins R., van den Berg S., Johansson A., Dahlgren L.G.,
RA   Hammarstrom M., Helleday T., Holmberg-Schiavone L., Karlberg T.,
RA   Weigelt J.;
RT   "Zinc binding catalytic domain of human tankyrase 1.";
RL   J. Mol. Biol. 379:136-145(2008).
RN   [19] {ECO:0007744|PDB:5GP7}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 799-957, FUNCTION, AND
RP   DEUBIQUITINATION BY USP25.
RX   PubMed=28619731; DOI=10.1101/gad.300889.117;
RA   Xu D., Liu J., Fu T., Shan B., Qian L., Pan L., Yuan J.;
RT   "USP25 regulates Wnt signaling by controlling the stability of
RT   tankyrases.";
RL   Genes Dev. 31:1024-1035(2017).
RN   [20] {ECO:0007744|PDB:7KKM, ECO:0007744|PDB:7KKN}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 1104-1314 IN COMPLEX WITH
RP   TALAZOPARIB INHIBITOR; OLAPARIB; NIRAPARIB AND VELIPARIB.
RX   PubMed=33361107; DOI=10.1074/jbc.ra120.016573;
RA   Ryan K., Bolanos B., Smith M., Palde P.B., Cuenca P.D., VanArsdale T.L.,
RA   Niessen S., Zhang L., Behenna D., Ornelas M.A., Tran K.T., Kaiser S.,
RA   Lum L., Stewart A., Gajiwala K.S.;
RT   "Dissecting the molecular determinants of clinical PARP1 inhibitor
RT   selectivity for tankyrase1.";
RL   J. Biol. Chem. 296:100251-100251(2021).
CC   -!- FUNCTION: Poly-ADP-ribosyltransferase involved in various processes
CC       such as Wnt signaling pathway, telomere length and vesicle trafficking
CC       (PubMed:10988299, PubMed:11739745, PubMed:16076287, PubMed:19759537,
CC       PubMed:21478859, PubMed:22864114, PubMed:23622245, PubMed:25043379,
CC       PubMed:28619731). Acts as an activator of the Wnt signaling pathway by
CC       mediating poly-ADP-ribosylation (PARsylation) of AXIN1 and AXIN2, 2 key
CC       components of the beta-catenin destruction complex: poly-ADP-
CC       ribosylated target proteins are recognized by RNF146, which mediates
CC       their ubiquitination and subsequent degradation (PubMed:19759537,
CC       PubMed:21478859). Also mediates PARsylation of BLZF1 and CASC3,
CC       followed by recruitment of RNF146 and subsequent ubiquitination
CC       (PubMed:21478859). Mediates PARsylation of TERF1, thereby contributing
CC       to the regulation of telomere length (PubMed:11739745). Involved in
CC       centrosome maturation during prometaphase by mediating PARsylation of
CC       HEPACAM2/MIKI (PubMed:22864114). May also regulate vesicle trafficking
CC       and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles
CC       (PubMed:10988299). May be involved in spindle pole assembly through
CC       PARsylation of NUMA1 (PubMed:16076287). Stimulates 26S proteasome
CC       activity (PubMed:23622245). {ECO:0000269|PubMed:10988299,
CC       ECO:0000269|PubMed:11739745, ECO:0000269|PubMed:16076287,
CC       ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21478859,
CC       ECO:0000269|PubMed:22864114, ECO:0000269|PubMed:23622245,
CC       ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:28619731}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + (ADP-D-ribosyl)n-acceptor = nicotinamide + (ADP-D-
CC         ribosyl)n+1-acceptor + H(+).; EC=2.4.2.30;
CC         Evidence={ECO:0000269|PubMed:19759537};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L-
CC         aspartyl-[protein] + nicotinamide; Xref=Rhea:RHEA:54424, Rhea:RHEA-
CC         COMP:9867, Rhea:RHEA-COMP:13832, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:29961, ChEBI:CHEBI:57540, ChEBI:CHEBI:138102;
CC         Evidence={ECO:0000305};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54425;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L-
CC         glutamyl-[protein] + nicotinamide; Xref=Rhea:RHEA:58224, Rhea:RHEA-
CC         COMP:10208, Rhea:RHEA-COMP:15089, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:29973, ChEBI:CHEBI:57540, ChEBI:CHEBI:142540;
CC         Evidence={ECO:0000305};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58225;
CC         Evidence={ECO:0000305};
CC   -!- ACTIVITY REGULATION: Specifically inhibited by XAV939, a small
CC       molecule, leading to inhibit the Wnt signaling pathway by stabilizing
CC       AXIN1 and AXIN2 (PubMed:19759537). Inhibited by talazoparib
CC       (PubMed:33361107). Not inhibited by olaparib, niraparib and veliparib
CC       (PubMed:33361107). {ECO:0000269|PubMed:19759537,
CC       ECO:0000269|PubMed:33361107}.
CC   -!- SUBUNIT: Oligomerizes and associates with TNKS2. Interacts with the
CC       cytoplasmic domain of LNPEP/Otase in SLC2A4/GLUT4-vesicles. Binds to
CC       the N-terminus of telomeric TERF1 via the ANK repeats. Found in a
CC       complex with POT1; TERF1 and TINF2 (PubMed:12768206). Interacts with
CC       AXIN1 (PubMed:19759537, PubMed:21478859, PubMed:21799911). Interacts
CC       with AXIN2 (PubMed:19759537, PubMed:21478859). Interacts with BLZF1 and
CC       CASC3 (PubMed:21478859). Interacts with NUMA1 (PubMed:12080061).
CC       {ECO:0000269|PubMed:12080061, ECO:0000269|PubMed:12768206,
CC       ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21478859,
CC       ECO:0000269|PubMed:21799911}.
CC   -!- INTERACTION:
CC       O95271; Q9NX46: ADPRS; NbExp=3; IntAct=EBI-1105254, EBI-718580;
CC       O95271; Q9HC77: CENPJ; NbExp=4; IntAct=EBI-1105254, EBI-946194;
CC       O95271; Q9NRI5: DISC1; NbExp=5; IntAct=EBI-1105254, EBI-529989;
CC       O95271; Q7L775: EPM2AIP1; NbExp=3; IntAct=EBI-1105254, EBI-6255981;
CC       O95271; Q96RU3: FNBP1; NbExp=4; IntAct=EBI-1105254, EBI-1111248;
CC       O95271; Q9NWT6: HIF1AN; NbExp=7; IntAct=EBI-1105254, EBI-745632;
CC       O95271; O75367-2: MACROH2A1; NbExp=6; IntAct=EBI-1105254, EBI-6249599;
CC       O95271; Q9Y530: OARD1; NbExp=3; IntAct=EBI-1105254, EBI-8502288;
CC       O95271; Q9NTX7: RNF146; NbExp=6; IntAct=EBI-1105254, EBI-722397;
CC       O95271; O00560: SDCBP; NbExp=5; IntAct=EBI-1105254, EBI-727004;
CC       O95271; P56279: TCL1A; NbExp=3; IntAct=EBI-1105254, EBI-749995;
CC       O95271; P54274: TERF1; NbExp=8; IntAct=EBI-1105254, EBI-710997;
CC       O95271; Q9C0C2: TNKS1BP1; NbExp=2; IntAct=EBI-1105254, EBI-2104458;
CC       O95271; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-1105254, EBI-1380492;
CC       O95271; O35625: Axin1; Xeno; NbExp=4; IntAct=EBI-1105254, EBI-2365912;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10523501,
CC       ECO:0000269|PubMed:21799911, ECO:0000269|PubMed:22864114}. Golgi
CC       apparatus membrane {ECO:0000269|PubMed:22864114}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:22864114}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome {ECO:0000269|PubMed:10523501,
CC       ECO:0000269|PubMed:21799911}. Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:10523501}. Chromosome, telomere
CC       {ECO:0000305|PubMed:9822378}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:16076287}. Note=Associated with the Golgi and with
CC       juxtanuclear SLC2A4/GLUT4-vesicles (PubMed:22864114). A minor
CC       proportion is also found at nuclear pore complexes and around the
CC       pericentriolar matrix of mitotic centromeres (PubMed:10523501). During
CC       interphase, a small fraction of TNKS is found in the nucleus,
CC       associated with TERF1 (PubMed:12768206). Localizes to spindle poles at
CC       mitosis onset via interaction with NUMA1 (PubMed:12080061).
CC       {ECO:0000269|PubMed:10523501, ECO:0000269|PubMed:12080061,
CC       ECO:0000269|PubMed:12768206, ECO:0000269|PubMed:22864114}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95271-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95271-2; Sequence=VSP_004538, VSP_004539;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; highest levels in testis.
CC   -!- PTM: Phosphorylated on serine residues by MAPK kinases upon insulin
CC       stimulation. Phosphorylated during mitosis.
CC       {ECO:0000269|PubMed:10988299}.
CC   -!- PTM: Ubiquitinated by RNF146 when auto-poly-ADP-ribosylated, leading to
CC       its degradation. Deubiquitinated by USP25; leading to stabilization
CC       (PubMed:28619731). {ECO:0000269|PubMed:21478859,
CC       ECO:0000269|PubMed:28619731}.
CC   -!- PTM: ADP-ribosylated (-auto). Poly-ADP-ribosylated protein is
CC       recognized by RNF146, followed by ubiquitination.
CC       {ECO:0000269|PubMed:21478859}.
CC   -!- SIMILARITY: Belongs to the ARTD/PARP family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/43534/TNKS";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF082556; AAC79841.1; -; mRNA.
DR   EMBL; AF082557; AAC79842.1; -; mRNA.
DR   EMBL; AF082558; AAC79843.1; -; mRNA.
DR   EMBL; AF082559; AAC79844.1; -; mRNA.
DR   EMBL; AC103834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021242; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC098394; AAH98394.1; -; mRNA.
DR   EMBL; AB209339; BAD92576.1; -; mRNA.
DR   CCDS; CCDS5974.1; -. [O95271-1]
DR   RefSeq; NP_003738.2; NM_003747.3. [O95271-1]
DR   PDB; 2RF5; X-ray; 2.30 A; A=1091-1325.
DR   PDB; 3UDD; X-ray; 1.95 A; A/B=1105-1327.
DR   PDB; 3UH2; X-ray; 2.00 A; A/B=1105-1327.
DR   PDB; 3UH4; X-ray; 2.00 A; A/B=1105-1327.
DR   PDB; 4DVI; X-ray; 1.90 A; A/B=1104-1314.
DR   PDB; 4I9I; X-ray; 2.40 A; A/B/C/D=1104-1314.
DR   PDB; 4K4E; X-ray; 2.30 A; A/B=1104-1314.
DR   PDB; 4K4F; X-ray; 2.90 A; A/B=1104-1314.
DR   PDB; 4KRS; X-ray; 2.29 A; A/B=1105-1327.
DR   PDB; 4LI6; X-ray; 2.05 A; A/B=1105-1327.
DR   PDB; 4LI7; X-ray; 2.20 A; A/B=1105-1327.
DR   PDB; 4LI8; X-ray; 2.52 A; A/B=1105-1327.
DR   PDB; 4MSG; X-ray; 1.80 A; A/B=1104-1314.
DR   PDB; 4MSK; X-ray; 2.30 A; A/B/C/D=1104-1314.
DR   PDB; 4MT9; X-ray; 2.00 A; A/B=1104-1314.
DR   PDB; 4N3R; X-ray; 1.90 A; A/B=1104-1314.
DR   PDB; 4N4V; X-ray; 2.00 A; A/B=1104-1314.
DR   PDB; 4OA7; X-ray; 2.30 A; A/B/C/D=1105-1313.
DR   PDB; 4TOR; X-ray; 1.50 A; A/B/C/D=1105-1315.
DR   PDB; 4TOS; X-ray; 1.80 A; A/B=1105-1315.
DR   PDB; 4U6A; X-ray; 2.37 A; A=1091-1325.
DR   PDB; 4UUH; X-ray; 2.52 A; A=1091-1325.
DR   PDB; 4UW1; X-ray; 3.37 A; A/B/C/D/E/F/G/H=1091-1325.
DR   PDB; 4W5S; X-ray; 2.80 A; A=1105-1314.
DR   PDB; 4W6E; X-ray; 1.95 A; A=1106-1314.
DR   PDB; 5EBT; X-ray; 2.24 A; A/B/C/D=1106-1314.
DR   PDB; 5ECE; X-ray; 2.20 A; A/B/C/D=1105-1316.
DR   PDB; 5ETY; X-ray; 2.90 A; A/B/C/D=1091-1324.
DR   PDB; 5GP7; X-ray; 1.50 A; A=799-957.
DR   PDB; 5JHQ; X-ray; 3.20 A; A/B/C/D=174-649.
DR   PDB; 5JTI; X-ray; 2.90 A; A/B/C/D/E/F=1018-1093.
DR   PDB; 5JU5; X-ray; 2.50 A; A/B/C/D/E/F=1018-1093.
DR   PDB; 5KNI; X-ray; 2.50 A; A/B/C/D/E/F/G=1026-1091.
DR   PDB; 6QXU; X-ray; 1.20 A; A=1104-1314.
DR   PDB; 6URQ; X-ray; 2.05 A; A/B=328-646.
DR   PDB; 7KKM; X-ray; 1.58 A; A/B/C/D=1104-1314.
DR   PDB; 7KKN; X-ray; 1.48 A; A/B/C/D=1104-1314.
DR   PDB; 7KKO; X-ray; 1.56 A; A/B/C=1104-1314.
DR   PDB; 7KKP; X-ray; 1.40 A; A/B=1104-1314.
DR   PDB; 7KKQ; X-ray; 1.59 A; A/B/C/D=1104-1314.
DR   PDB; 7OCV; X-ray; 1.43 A; A=1104-1314.
DR   PDB; 8X5J; X-ray; 1.70 A; A/B=1104-1314.
DR   PDBsum; 2RF5; -.
DR   PDBsum; 3UDD; -.
DR   PDBsum; 3UH2; -.
DR   PDBsum; 3UH4; -.
DR   PDBsum; 4DVI; -.
DR   PDBsum; 4I9I; -.
DR   PDBsum; 4K4E; -.
DR   PDBsum; 4K4F; -.
DR   PDBsum; 4KRS; -.
DR   PDBsum; 4LI6; -.
DR   PDBsum; 4LI7; -.
DR   PDBsum; 4LI8; -.
DR   PDBsum; 4MSG; -.
DR   PDBsum; 4MSK; -.
DR   PDBsum; 4MT9; -.
DR   PDBsum; 4N3R; -.
DR   PDBsum; 4N4V; -.
DR   PDBsum; 4OA7; -.
DR   PDBsum; 4TOR; -.
DR   PDBsum; 4TOS; -.
DR   PDBsum; 4U6A; -.
DR   PDBsum; 4UUH; -.
DR   PDBsum; 4UW1; -.
DR   PDBsum; 4W5S; -.
DR   PDBsum; 4W6E; -.
DR   PDBsum; 5EBT; -.
DR   PDBsum; 5ECE; -.
DR   PDBsum; 5ETY; -.
DR   PDBsum; 5GP7; -.
DR   PDBsum; 5JHQ; -.
DR   PDBsum; 5JTI; -.
DR   PDBsum; 5JU5; -.
DR   PDBsum; 5KNI; -.
DR   PDBsum; 6QXU; -.
DR   PDBsum; 6URQ; -.
DR   PDBsum; 7KKM; -.
DR   PDBsum; 7KKN; -.
DR   PDBsum; 7KKO; -.
DR   PDBsum; 7KKP; -.
DR   PDBsum; 7KKQ; -.
DR   PDBsum; 7OCV; -.
DR   PDBsum; 8X5J; -.
DR   AlphaFoldDB; O95271; -.
DR   SMR; O95271; -.
DR   BioGRID; 114207; 104.
DR   CORUM; O95271; -.
DR   DIP; DIP-36652N; -.
DR   ELM; O95271; -.
DR   FunCoup; O95271; 3965.
DR   IntAct; O95271; 79.
DR   MINT; O95271; -.
DR   STRING; 9606.ENSP00000311579; -.
DR   BindingDB; O95271; -.
DR   ChEMBL; CHEMBL6164; -.
DR   DrugBank; DB16063; 2X-121.
DR   DrugCentral; O95271; -.
DR   GuidetoPHARMACOLOGY; 3108; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   GlyGen; O95271; 4 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; O95271; -.
DR   PhosphoSitePlus; O95271; -.
DR   BioMuta; TNKS; -.
DR   jPOST; O95271; -.
DR   MassIVE; O95271; -.
DR   PaxDb; 9606-ENSP00000311579; -.
DR   PeptideAtlas; O95271; -.
DR   ProteomicsDB; 50772; -. [O95271-1]
DR   ProteomicsDB; 50773; -. [O95271-2]
DR   Pumba; O95271; -.
DR   ABCD; O95271; 1 sequenced antibody.
DR   Antibodypedia; 22078; 378 antibodies from 35 providers.
DR   DNASU; 8658; -.
DR   Ensembl; ENST00000310430.11; ENSP00000311579.6; ENSG00000173273.17. [O95271-1]
DR   Ensembl; ENST00000646522.2; ENSP00000493602.2; ENSG00000285372.2. [O95271-1]
DR   GeneID; 8658; -.
DR   KEGG; hsa:8658; -.
DR   MANE-Select; ENST00000310430.11; ENSP00000311579.6; NM_003747.3; NP_003738.2.
DR   UCSC; uc003wss.4; human. [O95271-1]
DR   AGR; HGNC:11941; -.
DR   CTD; 8658; -.
DR   DisGeNET; 8658; -.
DR   GeneCards; TNKS; -.
DR   HGNC; HGNC:11941; TNKS.
DR   HPA; ENSG00000173273; Low tissue specificity.
DR   MIM; 603303; gene.
DR   OpenTargets; ENSG00000173273; -.
DR   VEuPathDB; HostDB:ENSG00000173273; -.
DR   eggNOG; KOG4177; Eukaryota.
DR   GeneTree; ENSGT00940000156161; -.
DR   InParanoid; O95271; -.
DR   OMA; TAETINC; -.
DR   OrthoDB; 4772757at2759; -.
DR   PAN-GO; O95271; 7 GO annotations based on evolutionary models.
DR   PhylomeDB; O95271; -.
DR   BRENDA; 2.4.2.30; 2681.
DR   PathwayCommons; O95271; -.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-5545619; XAV939 stabilizes AXIN.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   SignaLink; O95271; -.
DR   SIGNOR; O95271; -.
DR   BioGRID-ORCS; 8658; 14 hits in 1163 CRISPR screens.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; DEE660B4; Stress granule.
DR   ChiTaRS; TNKS; human.
DR   EvolutionaryTrace; O95271; -.
DR   GeneWiki; TNKS; -.
DR   GenomeRNAi; 8658; -.
DR   Pharos; O95271; Tchem.
DR   PRO; PR:O95271; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; O95271; protein.
DR   Bgee; ENSG00000173273; Expressed in middle temporal gyrus and 204 other cell types or tissues.
DR   ExpressionAtlas; O95271; baseline and differential.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005643; C:nuclear pore; TAS:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000242; C:pericentriolar material; TAS:BHF-UCL.
DR   GO; GO:0042393; F:histone binding; IPI:BHF-UCL.
DR   GO; GO:0003950; F:NAD+ poly-ADP-ribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:1990404; F:NAD+-protein mono-ADP-ribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140806; F:NAD+-protein-aspartate ADP-ribosyltransferase activity; IEA:RHEA.
DR   GO; GO:0140807; F:NAD+-protein-glutamate ADP-ribosyltransferase activity; IEA:RHEA.
DR   GO; GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IDA:BHF-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007052; P:mitotic spindle organization; TAS:BHF-UCL.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:1904908; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; IMP:BHF-UCL.
DR   GO; GO:1904357; P:negative regulation of telomere maintenance via telomere lengthening; IMP:BHF-UCL.
DR   GO; GO:1904743; P:negative regulation of telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:MGI.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:1904358; P:positive regulation of telomere maintenance via telomere lengthening; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0070213; P:protein auto-ADP-ribosylation; IDA:UniProtKB.
DR   GO; GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL.
DR   GO; GO:0070212; P:protein poly-ADP-ribosylation; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0032210; P:regulation of telomere maintenance via telomerase; TAS:BHF-UCL.
DR   GO; GO:0051225; P:spindle assembly; TAS:BHF-UCL.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd09524; SAM_tankyrase1_2; 1.
DR   CDD; cd01438; tankyrase_like; 1.
DR   FunFam; 1.10.150.50:FF:000012; Poly [ADP-ribose] polymerase; 1.
DR   FunFam; 1.25.40.20:FF:000009; Poly [ADP-ribose] polymerase; 1.
DR   FunFam; 1.25.40.20:FF:000010; Poly [ADP-ribose] polymerase; 1.
DR   FunFam; 1.25.40.20:FF:000011; Poly [ADP-ribose] polymerase; 1.
DR   FunFam; 1.25.40.20:FF:000021; Poly [ADP-ribose] polymerase; 1.
DR   FunFam; 1.25.40.20:FF:000024; Poly [ADP-ribose] polymerase; 1.
DR   FunFam; 3.90.228.10:FF:000001; Poly [ADP-ribose] polymerase tankyrase-2; 1.
DR   Gene3D; 3.90.228.10; -; 1.
DR   Gene3D; 6.20.320.10; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 5.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR24171:SF9; ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 39; 1.
DR   PANTHER; PTHR24171; ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 39-RELATED; 1.
DR   Pfam; PF00023; Ank; 4.
DR   Pfam; PF12796; Ank_2; 5.
DR   Pfam; PF00644; PARP; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 17.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF56399; ADP-ribosylation; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 3.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 15.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
DR   neXtProt; NX_O95271; -.
DR   PharmGKB; PA36631; -.
DR   TreeFam; TF326036; -.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Alternative splicing; ANK repeat;
KW   Cell cycle; Cell division; Chromosome; Cytoplasm; Cytoskeleton;
KW   Glycosyltransferase; Golgi apparatus; Membrane; Metal-binding; Mitosis;
KW   mRNA transport; NAD; Nuclear pore complex; Nucleotidyltransferase; Nucleus;
KW   Phosphoprotein; Protein transport; Proteomics identification;
KW   Reference proteome; Repeat; Telomere; Transferase; Translocation;
KW   Transport; Ubl conjugation; Wnt signaling pathway; Zinc.
FT   CHAIN           1..1327
FT                   /note="Poly [ADP-ribose] polymerase tankyrase-1"
FT                   /id="PRO_0000211333"
FT   REPEAT          181..209
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          215..244
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          248..277
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          281..310
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          335..364
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          368..397
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          401..430
FT                   /note="ANK 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          434..463
FT                   /note="ANK 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          521..553
FT                   /note="ANK 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          557..586
FT                   /note="ANK 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          590..619
FT                   /note="ANK 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          621..647
FT                   /note="ANK 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          649..679
FT                   /note="ANK 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          683..712
FT                   /note="ANK 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          716..745
FT                   /note="ANK 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          749..778
FT                   /note="ANK 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          782..810
FT                   /note="ANK 17"
FT                   /evidence="ECO:0000255"
FT   REPEAT          836..865
FT                   /note="ANK 18"
FT                   /evidence="ECO:0000255"
FT   REPEAT          869..898
FT                   /note="ANK 19"
FT                   /evidence="ECO:0000255"
FT   REPEAT          902..931
FT                   /note="ANK 20"
FT                   /evidence="ECO:0000255"
FT   REPEAT          935..964
FT                   /note="ANK 21"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1030..1089
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          1112..1317
FT                   /note="PARP catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00397"
FT   REGION          1..91
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          112..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..15
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        25..36
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        69..82
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        112..154
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1234
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18436240,
FT                   ECO:0007744|PDB:2RF5, ECO:0007744|PDB:3UDD,
FT                   ECO:0007744|PDB:3UH2, ECO:0007744|PDB:3UH4,
FT                   ECO:0007744|PDB:4DVI, ECO:0007744|PDB:4I9I,
FT                   ECO:0007744|PDB:4K4E, ECO:0007744|PDB:4K4F,
FT                   ECO:0007744|PDB:4KRS, ECO:0007744|PDB:4LI6,
FT                   ECO:0007744|PDB:4LI8, ECO:0007744|PDB:4MSG,
FT                   ECO:0007744|PDB:4MSK, ECO:0007744|PDB:4MT9,
FT                   ECO:0007744|PDB:4N3R, ECO:0007744|PDB:4N4V,
FT                   ECO:0007744|PDB:4OA7, ECO:0007744|PDB:4TOR,
FT                   ECO:0007744|PDB:4TOS, ECO:0007744|PDB:4W5S,
FT                   ECO:0007744|PDB:4W6E"
FT   BINDING         1237
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18436240,
FT                   ECO:0007744|PDB:2RF5, ECO:0007744|PDB:3UDD,
FT                   ECO:0007744|PDB:3UH2, ECO:0007744|PDB:3UH4,
FT                   ECO:0007744|PDB:4DVI, ECO:0007744|PDB:4I9I,
FT                   ECO:0007744|PDB:4K4E, ECO:0007744|PDB:4K4F,
FT                   ECO:0007744|PDB:4KRS, ECO:0007744|PDB:4LI6,
FT                   ECO:0007744|PDB:4LI8, ECO:0007744|PDB:4MSG,
FT                   ECO:0007744|PDB:4MSK, ECO:0007744|PDB:4MT9,
FT                   ECO:0007744|PDB:4N3R, ECO:0007744|PDB:4N4V,
FT                   ECO:0007744|PDB:4OA7, ECO:0007744|PDB:4TOR,
FT                   ECO:0007744|PDB:4TOS, ECO:0007744|PDB:4W5S,
FT                   ECO:0007744|PDB:4W6E"
FT   BINDING         1242
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18436240,
FT                   ECO:0007744|PDB:2RF5, ECO:0007744|PDB:3UDD,
FT                   ECO:0007744|PDB:3UH2, ECO:0007744|PDB:3UH4,
FT                   ECO:0007744|PDB:4DVI, ECO:0007744|PDB:4I9I,
FT                   ECO:0007744|PDB:4K4E, ECO:0007744|PDB:4K4F,
FT                   ECO:0007744|PDB:4KRS, ECO:0007744|PDB:4LI6,
FT                   ECO:0007744|PDB:4LI8, ECO:0007744|PDB:4MSG,
FT                   ECO:0007744|PDB:4MSK, ECO:0007744|PDB:4MT9,
FT                   ECO:0007744|PDB:4N3R, ECO:0007744|PDB:4N4V,
FT                   ECO:0007744|PDB:4OA7, ECO:0007744|PDB:4TOR,
FT                   ECO:0007744|PDB:4TOS, ECO:0007744|PDB:4W5S,
FT                   ECO:0007744|PDB:4W6E"
FT   BINDING         1245
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:18436240,
FT                   ECO:0007744|PDB:2RF5, ECO:0007744|PDB:3UDD,
FT                   ECO:0007744|PDB:3UH2, ECO:0007744|PDB:3UH4,
FT                   ECO:0007744|PDB:4DVI, ECO:0007744|PDB:4I9I,
FT                   ECO:0007744|PDB:4K4E, ECO:0007744|PDB:4K4F,
FT                   ECO:0007744|PDB:4KRS, ECO:0007744|PDB:4LI6,
FT                   ECO:0007744|PDB:4LI8, ECO:0007744|PDB:4MSG,
FT                   ECO:0007744|PDB:4MSK, ECO:0007744|PDB:4MT9,
FT                   ECO:0007744|PDB:4N3R, ECO:0007744|PDB:4N4V,
FT                   ECO:0007744|PDB:4OA7, ECO:0007744|PDB:4TOR,
FT                   ECO:0007744|PDB:4TOS, ECO:0007744|PDB:4W5S,
FT                   ECO:0007744|PDB:4W6E"
FT   VAR_SEQ         641..643
FT                   /note="EST -> GHS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9822378"
FT                   /id="VSP_004538"
FT   VAR_SEQ         644..1327
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9822378"
FT                   /id="VSP_004539"
FT   MUTAGEN         1184
FT                   /note="H->A: Loss of activity; when associated with
FT                   A-1291."
FT                   /evidence="ECO:0000269|PubMed:11739745"
FT   MUTAGEN         1291
FT                   /note="E->A: Loss of activity; when associated with
FT                   A-1184."
FT                   /evidence="ECO:0000269|PubMed:11739745"
FT   CONFLICT        83
FT                   /note="P -> Q (in Ref. 4; AAH98394)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        802
FT                   /note="R -> K (in Ref. 1; AAC79841/AAC79842)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1001
FT                   /note="E -> G (in Ref. 4; AAH98394)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1266
FT                   /note="M -> I (in Ref. 4; AAH98394)"
FT                   /evidence="ECO:0000305"
FT   HELIX           182..192
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           195..201
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   TURN            204..208
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   TURN            212..215
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           219..225
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           229..237
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           252..258
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           262..270
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           285..291
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           295..303
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   TURN            318..321
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           324..329
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   TURN            330..332
FT                   /evidence="ECO:0007829|PDB:5JHQ"
FT   HELIX           334..345
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           348..354
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   TURN            357..361
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           372..378
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           382..390
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           405..411
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           415..423
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           438..444
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           448..456
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           471..474
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           478..498
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           502..510
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           513..515
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   TURN            519..521
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           525..531
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           537..546
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           561..567
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           571..579
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           594..601
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           604..612
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           628..630
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           633..640
FT                   /evidence="ECO:0007829|PDB:6URQ"
FT   HELIX           799..813
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           816..822
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   TURN            825..829
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   TURN            833..836
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           840..846
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           850..858
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           873..880
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           883..891
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           906..913
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           916..924
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           939..942
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           946..955
FT                   /evidence="ECO:0007829|PDB:5GP7"
FT   HELIX           1031..1037
FT                   /evidence="ECO:0007829|PDB:5JU5"
FT   HELIX           1041..1043
FT                   /evidence="ECO:0007829|PDB:5JU5"
FT   HELIX           1044..1049
FT                   /evidence="ECO:0007829|PDB:5JU5"
FT   HELIX           1054..1058
FT                   /evidence="ECO:0007829|PDB:5JU5"
FT   HELIX           1062..1067
FT                   /evidence="ECO:0007829|PDB:5JU5"
FT   HELIX           1073..1086
FT                   /evidence="ECO:0007829|PDB:5JU5"
FT   STRAND          1107..1110
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1116..1127
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   TURN            1133..1139
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1145..1154
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1156..1172
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   TURN            1173..1175
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1179..1184
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1189..1195
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1199..1201
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1202..1205
FT                   /evidence="ECO:0007829|PDB:4TOS"
FT   STRAND          1209..1217
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1218..1222
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   TURN            1223..1226
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1228..1230
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   TURN            1235..1237
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1243..1245
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1247..1255
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1258..1264
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1268..1270
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1276..1280
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1282..1284
FT                   /evidence="ECO:0007829|PDB:3UDD"
FT   STRAND          1286..1289
FT                   /evidence="ECO:0007829|PDB:4TOR"
FT   STRAND          1291..1296
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   HELIX           1297..1299
FT                   /evidence="ECO:0007829|PDB:6QXU"
FT   STRAND          1300..1310
FT                   /evidence="ECO:0007829|PDB:6QXU"
SQ   SEQUENCE   1327 AA;  142039 MW;  44BDE985C715BEFF CRC64;
     MAASRRSQHH HHHHQQQLQP APGASAPPPP PPPPLSPGLA PGTTPASPTA SGLAPFASPR
     HGLALPEGDG SRDPPDRPRS PDPVDGTSCC STTSTICTVA AAPVVPAVST SSAAGVAPNP
     AGSGSNNSPS SSSSPTSSSS SSPSSPGSSL AESPEAAGVS STAPLGPGAA GPGTGVPAVS
     GALRELLEAC RNGDVSRVKR LVDAANVNAK DMAGRKSSPL HFAAGFGRKD VVEHLLQMGA
     NVHARDDGGL IPLHNACSFG HAEVVSLLLC QGADPNARDN WNYTPLHEAA IKGKIDVCIV
     LLQHGADPNI RNTDGKSALD LADPSAKAVL TGEYKKDELL EAARSGNEEK LMALLTPLNV
     NCHASDGRKS TPLHLAAGYN RVRIVQLLLQ HGADVHAKDK GGLVPLHNAC SYGHYEVTEL
     LLKHGACVNA MDLWQFTPLH EAASKNRVEV CSLLLSHGAD PTLVNCHGKS AVDMAPTPEL
     RERLTYEFKG HSLLQAAREA DLAKVKKTLA LEIINFKQPQ SHETALHCAV ASLHPKRKQV
     TELLLRKGAN VNEKNKDFMT PLHVAAERAH NDVMEVLHKH GAKMNALDTL GQTALHRAAL
     AGHLQTCRLL LSYGSDPSII SLQGFTAAQM GNEAVQQILS ESTPIRTSDV DYRLLEASKA
     GDLETVKQLC SSQNVNCRDL EGRHSTPLHF AAGYNRVSVV EYLLHHGADV HAKDKGGLVP
     LHNACSYGHY EVAELLVRHG ASVNVADLWK FTPLHEAAAK GKYEICKLLL KHGADPTKKN
     RDGNTPLDLV KEGDTDIQDL LRGDAALLDA AKKGCLARVQ KLCTPENINC RDTQGRNSTP
     LHLAAGYNNL EVAEYLLEHG ADVNAQDKGG LIPLHNAASY GHVDIAALLI KYNTCVNATD
     KWAFTPLHEA AQKGRTQLCA LLLAHGADPT MKNQEGQTPL DLATADDIRA LLIDAMPPEA
     LPTCFKPQAT VVSASLISPA STPSCLSAAS SIDNLTGPLA ELAVGGASNA GDGAAGTERK
     EGEVAGLDMN ISQFLKSLGL EHLRDIFETE QITLDVLADM GHEELKEIGI NAYGHRHKLI
     KGVERLLGGQ QGTNPYLTFH CVNQGTILLD LAPEDKEYQS VEEEMQSTIR EHRDGGNAGG
     IFNRYNVIRI QKVVNKKLRE RFCHRQKEVS EENHNHHNER MLFHGSPFIN AIIHKGFDER
     HAYIGGMFGA GIYFAENSSK SNQYVYGIGG GTGCPTHKDR SCYICHRQML FCRVTLGKSF
     LQFSTMKMAH APPGHHSVIG RPSVNGLAYA EYVIYRGEQA YPEYLITYQI MKPEAPSQTA
     TAAEQKT
//
